← Eichor
Condition: Hepatocellular Carcinoma With Pvtt Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatocellular Carcinoma With Pvtt

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
NA · 1 location(s) · Sun Yat-sen University · NCT06622031
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT03368651
Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
Phase 2 · 1 location(s) · Yongyi Zeng · NCT06349317
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Phase 2 · 1 location(s) · Fei Gao · NCT06646198
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06904183
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06031285
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07327788
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
Phase 3 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06492395
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05984511
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07062055
TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06669377
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
Phase 2 · 1 location(s) · West China Hospital · NCT06664996
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.